Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Exicure, Inc.
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K
April 22, 2024
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis
February 05, 2024
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
November 28, 2023
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
August 23, 2023
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 11, 2023
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update
July 14, 2023
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives
May 26, 2023
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
May 19, 2023
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld
May 04, 2023
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
April 27, 2023
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate Update
March 27, 2023
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Announces Closing of Private Placement Transaction with CBI USA, Inc. and Changes to the Board of Directors
February 24, 2023
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements
December 14, 2022
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 14, 2022
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic Alternatives
September 26, 2022
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure Announces Presentation at Chardan’s 6th Annual Genetic Medicines Conference
September 01, 2022
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress
August 15, 2022
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement
July 20, 2022
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split
June 29, 2022
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Announces Adjournment of Annual Meeting of Stockholders
May 27, 2022
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure Announces Presentation at 2022 H.C. Wainwright Global Life Sciences Conference
May 17, 2022
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Reports First Quarter 2022 Financial Results and Corporate Progress
May 16, 2022
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure Announces $5 Million Raise in Private Placement Transaction Priced at Market Premium
May 10, 2022
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure to Present at Upcoming TIDES USA Oligonucleotide & Peptide Therapeutics Conference
May 09, 2022
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Reports Full Year 2021 Financial Results and Corporate Progress
March 25, 2022
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Announces Leadership Transition and Changes to the Board of Directors
February 04, 2022
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Announces $11.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
December 14, 2021
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Announces Results of Internal Investigation and Implementation of Strategic Measures to Reduce Cash Burn and Prioritize Pipeline Focus
December 10, 2021
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure, Inc. Reports Third Quarter 2021 Financial Results and Corporate Progress
November 19, 2021
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Exicure Files Form 12b-25
November 15, 2021
From
Exicure, Inc.
Via
Business Wire
Tickers
XCUR
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.